BioAptagen

Guwahati, India Founded: 2019 • Age: 7 yrs
Develops innovative diagnostic kits for detecting disease cells in biological fluids.
Annual revenue $23,848 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About BioAptagen

BioAptagen is a company based in Guwahati (India) founded in 2019 by Swapnil Sinha and Shubhangi Kaushik. It operates as a B2B. BioAptagen operates in a competitive market with competitors including Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.

  • Headquarter Guwahati, India
  • Founders Swapnil Sinha, Shubhangi Kaushik
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Altanostics Labs Private Limited
  • Date of Incorporation 20 Sep, 2018
  • Jurisdiction Faizabad, Uttar Pradesh, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $23.85 K (USD)
    358.33
    as on Mar 31, 2020
  • Net Profit
    Not available
  • EBITDA
    -$13.53 K (USD)
    -260.53
    as on Mar 31, 2020
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BioAptagen

Premium access

Detailed funding history for BioAptagen

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioAptagen

Investments
Premium access

Investment portfolio details for BioAptagen

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BioAptagen

Premium access

Detailed financials for BioAptagen

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bioaptagen Comparisons

BioAptagen Primary company
Description
Develops innovative diagnostic kits for detecting disease ce...
Location
Guwahati, India
Founded Year
2019
Annual Revenue
$23.85 K (USD)
Net Profit
Not available
EBITDA
-$13.53 K (USD)
Employees
Not available
Premium access

Peer comparison for BioAptagen

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BioAptagen

BioAptagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of diagnostic solutions for systemic infections
Locked Locked Locked
Provider of machine learning based diagnostic solutions for infectious diseases
Locked Locked Locked
Instruments and test panels for multiplexed molecular diagnostics are provided.
Locked Locked Locked
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
Locked Locked Locked
Miniaturized MRI platforms for clinical diagnostics are developed.
Locked Locked Locked
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
Premium access

Detailed competitors of BioAptagen

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bioaptagen

Premium access

Complete news archive for BioAptagen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioAptagen

BioAptagen was founded in 2019.

BioAptagen is headquartered in Guwahati, India. It is registered at Guwahati, Assam, India.

Swapnil Sinha is the current CEO of BioAptagen. They have also founded this company.

Annual revenue of BioAptagen is $23.85K as on Mar 31, 2020.

BioAptagen develops innovative diagnostic kits for detecting disease cells in biological fluids through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and cell detection. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

BioAptagen's top competitors include Visby Medical, Inflammatix and MeMed.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available